| Ashley Morgan Wohleber Scott, PSYD | |
|
4455 Ne Highway 20, Corvallis, OR 97330 | |
| (541) 758-5900 | |
| (541) 752-9270 |
| Full Name | Ashley Morgan Wohleber Scott |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 4455 Ne Highway 20, Corvallis, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306143292 | NPI | - | NPPES |
| 500666679 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2512 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Morgan Wohleber Scott, PSYD 3415 Se Powell Boulevard, Portland, OR 97202 Ph: (541) 758-5900 | Ashley Morgan Wohleber Scott, PSYD 4455 Ne Highway 20, Corvallis, OR 97330 Ph: (541) 758-5900 |
News Archive
Canadians can join hands in a virtual community with the Meningitis Research Foundation of Canada and become a member of the global family by visiting www.comoonline.org and "joining hands" in the fight against meningitis, and to show support for meningitis awareness and prevention.
In Maryland, Vermont and Oregon, state officials are still hammering out technological issues preventing consumers from signing up for coverage. In California, in contrast, the pace of enrollment in December has been nearly three times that of a month earlier as the deadline approaches to sign up for coverage that takes effect Jan. 1.
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.
The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug's developer, OSI Pharmaceuticals, Inc.
› Verified 5 days ago
Dr. Rex W Turner, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 981 Nw Spruce Ave, Corvallis, OR 97330 Phone: 541-758-0766 | |
Joel Garfunkel, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 444 Nw Elks Dr, Corvallis, OR 97330 Phone: 541-754-1150 | |
Dr. Paige Kimberly Warner, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 744 Nw 4th St, Corvallis, OR 97330 Phone: 541-752-2700 | |
Dr. Erin Fuller Crozier, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 518 Sw 3rd St Ste E, Corvallis, OR 97333 Phone: 541-787-3187 Fax: 541-787-3187 | |
Mr. Markham Scott Giblin, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1300 Nw Harrison Blvd, Ste # 140, Corvallis, OR 97330 Phone: 541-738-6516 Fax: 541-738-6517 | |
Kent S Hill, LCP, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 530 Nw 27th St, Corvallis, OR 97330 Phone: 541-766-6835 Fax: 541-766-6186 | |
Julie A Evans Watkins, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 260 Sw Madison Ave Ste 116, Corvallis, OR 97333 Phone: 541-295-0157 |